Ameriprise warns AI spending outpaces revenue growth ahead of hyperscaler earnings
Bitget2026/10/19 19:35- Ameriprise Financial warned that AI spending plans may need resetting unless revenue growth accelerates, ahead of key hyperscaler earnings reports.
- Consensus capital expenditure estimates for the largest AI spenders more than doubled over the past year; revenue estimates rose roughly 25%.
- The five major hyperscalers are forecast to spend over $1 trillion combined on capital expenditures over the next 12 months.
- Meta reports Wednesday, with other major hyperscalers reporting next week; investors will scrutinize monetization, cash generation and expansion funding.
- Financing strains intensified as CoreWeave bonds traded at distressed levels, highlighting growing investor demands for clearer returns on AI infrastructure spending.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S&P Dow Jones Partners With Kalshi as Prediction Markets Enter Mainstream
130% Near Protocol (NEAR) Surge in Spot Inflows Secures $1.3 Million

Unable to recover 817 bitcoin, Datavault AI (DVLT.US) stock price slashed in half
Datavault AI has confirmed that it has been unable to withdraw Bitcoin from Biconomy since June, resulting in a failed asset transfer and forcing the company to restate its financial reports. As a result, its share price plummeted by 49.55% in a single day, and its book assets are expected to shrink significantly.

Regenerative medicine device company RegenLab USA (RGNA.US) sets IPO price at $6–$8 per share, aiming to raise $18 million
RegenLab USA announced its IPO terms on Tuesday.